Gut microbial health could be key to health disparities
A UF infectious disease expert underscores a call for research into connections between the gut microbiome and health inequities.
Posted in
Recent News
Untangling drivers of dengue in Thailand
New work by a UF biologist uses mobility data and genetic sequencing to reconstruct how dengue viruses circulate within Thailand.
UF’s EPI supports testing for new technology to kill space microbes
UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.
Yunnan orbivirus found in Florida for first time
UF researchers find first known instance of Yunnan orbivirus in North America from postmortem tests on tissues from a farmed white-tailed deer in Florida.
Modeling Covid-19 vaccination efforts in the U.S.
Recent work contributed to by UF mathematician Burton Singer seeks to estimate how COVID-19 vaccination campaigns will affect the future trajectory of the pandemic in the US.
Casting light on Covid-19 ‘guest’ agricultural workers
An editorial by UF professors, published in the American Journal of Public Health, casts a spotlight on the plight of guest agricultural workers during the pandemic.
Mapping the spread of Covid-19 in Brazil
New research published in Science looks back at how COVID-19 spread over time throughout Brazil, to create a pandemic hotspot.
Understanding salmonella infections in Florida
New research by UF investigators on Salmonella infections in Florida highlights the influence of seasons, geography and age upon transmission patterns. The team also developed new AI-based methods for detecting outbreaks and linking cases to environmental or food sources.
New malaria vaccine candidate seeks to block transmission
Two new studies advance a potentially groundbreaking transmission-blocking malaria vaccine. UF researcher Rhoel Dinglasan's approach is completely different: Immunizing mosquitoes with malaria transmission-blocking antibodies produced in people.
Covid-19 vaccine effective against new variant in Brazil
UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.
